Soleno Therapeutics, Inc. (NASDAQ:SLNO) ranks among the most oversold biotech stocks to invest in. Soleno Therapeutics, Inc. (NASDAQ:SLNO) reported third-quarter adjusted earnings of $0.47 per share ...
SOLENO THERAPEUTICS ($SLNO) posted quarterly earnings results on Wednesday, May 7th. The company reported earnings of -$0.95 per share, missing estimates of -$0.95 by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback